The Ensign Group, Inc. (ENSG)
NASDAQ: ENSG · IEX Real-Time Price · USD
117.25
-0.04 (-0.03%)
Apr 26, 2024, 4:00 PM EDT - Market closed
The Ensign Group Revenue
In the year 2023, The Ensign Group had annual revenue of $3.73B with 23.27% growth. Revenue in the quarter ending December 31, 2023 was $980.38M with 21.10% year-over-year growth.
Revenue (ttm)
$3.73B
Revenue Growth
+23.27%
P/S Ratio
1.78
Revenue / Employee
$105,647
Employees
35,300
Market Cap
6.64B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 3.73B | 703.89M | 23.27% |
Dec 31, 2022 | 3.03B | 398.01M | 15.15% |
Dec 31, 2021 | 2.63B | 224.87M | 9.36% |
Dec 31, 2020 | 2.40B | 366.07M | 17.98% |
Dec 31, 2019 | 2.04B | 281.92M | 16.07% |
Dec 31, 2018 | 1.75B | 156.28M | 9.78% |
Dec 31, 2017 | 1.60B | -56.54M | -3.42% |
Dec 31, 2016 | 1.65B | 313.04M | 23.33% |
Dec 31, 2015 | 1.34B | 314.42M | 30.60% |
Dec 31, 2014 | 1.03B | 122.85M | 13.58% |
Dec 31, 2013 | 904.56M | 81.40M | 9.89% |
Dec 31, 2012 | 823.16M | 64.88M | 8.56% |
Dec 31, 2011 | 758.28M | 108.75M | 16.74% |
Dec 31, 2010 | 649.53M | 107.53M | 19.84% |
Dec 31, 2009 | 542.00M | 72.63M | 15.47% |
Dec 31, 2008 | 469.37M | 58.05M | 14.11% |
Dec 31, 2007 | 411.32M | 52.74M | 14.71% |
Dec 31, 2006 | 358.57M | 57.72M | 19.19% |
Dec 31, 2005 | 300.85M | 56.31M | 23.03% |
Dec 31, 2004 | 244.54M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Elanco Animal Health | 4.42B |
DENTSPLY SIRONA | 3.97B |
Jazz Pharmaceuticals | 3.83B |
Acadia Healthcare Company | 2.93B |
Globus Medical | 1.57B |
HealthEquity | 999.59M |
Ionis Pharmaceuticals | 787.65M |
Revolution Medicines | 11.58M |
ENSG News
- 1 day ago - The Ensign Group Schedules First Quarter Earnings Call for Thursday, May 2, 2024 - GlobeNewsWire
- 5 weeks ago - The Ensign Group, Inc. Declares Quarterly Dividend of $0.06 Per Share - GlobeNewsWire
- 6 weeks ago - The Ensign Group to Present at the Oppenheimer & Co. Inc. 34th Annual Healthcare Conference - GlobeNewsWire
- 7 weeks ago - The Ensign Group Acquires Skilled Nursing Facility in Kansas - GlobeNewsWire
- 7 weeks ago - The Ensign Group Acquires Two Skilled Nursing Facilities in Colorado - GlobeNewsWire
- 3 months ago - The Ensign Group Reports Fiscal Year and Fourth Quarter 2023 Results; Issues 2024 Earnings Guidance - GlobeNewsWire
- 3 months ago - The Ensign Group Schedules Year-End 2023 Earnings Call for Friday, February 2, 2024 - GlobeNewsWire
- 3 months ago - Taura Gold Inc. Provides an Update on The Proposed Reverse Take-Over with Ensign Minerals Inc. - Accesswire